MOTS-c: The Mitochondrial Peptide That Mimics Exercise and Fights Aging — Even When Started Late in Life
The mitochondrial peptide MOTS-c improved physical performance in mice of all ages — including when started very late in life — and exercise naturally boosts MOTS-c levels in human muscle and blood.
Quick Facts
What This Study Found
MOTS-c, a peptide encoded by mitochondrial DNA, significantly enhanced physical performance in young (2 months), middle-aged (12 months), and old (22 months) mice. Most remarkably, when MOTS-c treatment was started very late in life (23.5 months — equivalent to roughly 70+ human years) at just 3 times per week, it still increased physical capacity and healthspan.
The study also showed that exercise naturally increases MOTS-c levels in both skeletal muscle and blood circulation in humans, establishing MOTS-c as an exercise-induced factor. At the molecular level, MOTS-c regulates nuclear genes related to metabolism and protein quality control (proteostasis), directly affects skeletal muscle metabolism, and helps muscle cells (myoblasts) adapt to metabolic stress.
Key Numbers
Enhanced performance in mice at 2, 12, and 22 months · late-life treatment started at 23.5 months · 3x/week intermittent dosing · exercise induces MOTS-c in human muscle + circulation · regulates nuclear gene expression
How They Did This
Multi-component study combining mouse experiments and human exercise data. Mice at three age groups received MOTS-c and were tested for physical performance. A separate cohort started treatment at 23.5 months (late life) with intermittent 3x/week dosing. In humans, skeletal muscle biopsies and blood samples were collected before and after exercise to measure endogenous MOTS-c levels. Molecular analyses included gene expression profiling, metabolomics in skeletal muscle, and myoblast stress response assays.
Why This Research Matters
This is one of the most important MOTS-c studies published because it demonstrates three critical things: (1) a mitochondrial-encoded peptide can actively regulate the aging process, (2) even late-life treatment can improve physical function, and (3) exercise naturally produces MOTS-c in humans. The finding that intermittent MOTS-c treatment started in very old mice still improved healthspan challenges the assumption that anti-aging interventions must start early to be effective. It also positions MOTS-c as a potential exercise mimetic for people who cannot exercise.
The Bigger Picture
MOTS-c belongs to a newly discovered class of peptides encoded by mitochondrial DNA — challenging the old view that mitochondria are just energy factories. This study from Nature Communications positions MOTS-c as a genuine exercise mimetic and aging regulator. The finding that late-life treatment still works is particularly significant for the aging research field, which has long debated whether interventions must start early. MOTS-c is now one of the most studied mitochondrial-derived peptides, alongside humanin.
What This Study Doesn't Tell Us
While MOTS-c improved physical capacity in mice, the study does not fully characterize all aspects of healthspan (cognitive function, organ-specific aging, etc.). The human component confirms that exercise induces MOTS-c but does not test exogenous MOTS-c administration in humans. Specific dosing details and the magnitude of physical performance improvements are not detailed in the abstract. Long-term safety of exogenous MOTS-c in any species remains to be established. The mechanisms by which a mitochondrial-encoded peptide regulates nuclear gene expression are still being elucidated.
Questions This Raises
- ?Could exogenous MOTS-c administration improve physical function in elderly or frail humans who cannot exercise?
- ?What is the optimal dosing regimen for MOTS-c to maximize healthspan benefits while minimizing any risks?
- ?How does MOTS-c communicate from the mitochondria to the nucleus to regulate gene expression — what is the signaling pathway?
Trust & Context
- Key Stat:
- Late-life effective MOTS-c treatment started at 23.5 months (very old age in mice) with just 3x/week dosing still improved physical capacity and healthspan
- Evidence Grade:
- Published in Nature Communications, this study combines rigorous mouse experiments across multiple age groups with human exercise data. The 'Strong' grade reflects the high-impact journal, the comprehensive age-spanning design, and the inclusion of both animal and human components.
- Study Age:
- Published in 2021, this is a recent and highly influential study. It built on earlier MOTS-c research from the same group (Cohen/Lee labs) and has become one of the most-cited papers in the mitochondrial-derived peptide field.
- Original Title:
- MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.
- Published In:
- Nature communications, 12(1), 470 (2021)
- Authors:
- Reynolds, Joseph C(2), Lai, Rochelle W, Woodhead, Jonathan S T(4), Joly, James H, Mitchell, Cameron J, Cameron-Smith, David, Lu, Ryan, Cohen, Pinchas, Graham, Nicholas A, Benayoun, Bérénice A, Merry, Troy L, Lee, Changhan
- Database ID:
- RPEP-05720
Evidence Hierarchy
Frequently Asked Questions
What is MOTS-c and where does it come from?
MOTS-c is a 16-amino acid peptide encoded by your mitochondrial DNA — the small, separate genome inside your mitochondria (the energy-producing structures in every cell). Unlike most proteins, which are encoded by nuclear DNA, MOTS-c is one of a handful of peptides produced directly by mitochondria. It circulates in the blood and can signal to the nucleus to change gene expression, effectively allowing your mitochondria to communicate with the rest of the cell.
Does this mean MOTS-c could replace exercise?
Not exactly, but it could partially replicate some of exercise's benefits. Exercise naturally increases MOTS-c production, and this study shows that administering MOTS-c externally produces exercise-like improvements in physical function. For elderly or disabled people who cannot exercise, MOTS-c could potentially deliver some of the metabolic and muscular benefits of physical activity. However, exercise has many other effects beyond MOTS-c that a single peptide likely cannot fully replicate.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05720APA
Reynolds, Joseph C; Lai, Rochelle W; Woodhead, Jonathan S T; Joly, James H; Mitchell, Cameron J; Cameron-Smith, David; Lu, Ryan; Cohen, Pinchas; Graham, Nicholas A; Benayoun, Bérénice A; Merry, Troy L; Lee, Changhan. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.. Nature communications, 12(1), 470. https://doi.org/10.1038/s41467-020-20790-0
MLA
Reynolds, Joseph C, et al. "MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.." Nature communications, 2021. https://doi.org/10.1038/s41467-020-20790-0
RethinkPeptides
RethinkPeptides Research Database. "MOTS-c is an exercise-induced mitochondrial-encoded regulato..." RPEP-05720. Retrieved from https://rethinkpeptides.com/research/reynolds-2021-motsc-is-an-exerciseinduced
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.